Best Abstracts: Endovascular | Peripheral Vascular Intervention Two

Moderator(s)

• 

  Carlos Mena, MD

  Director Cardiac Catheterization Laboratories. Director Vascular Medicine
  Yale University
  Branford, Connecticut, United States

  Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consultant (Ongoing); Cookmedical: Consultant (Ongoing); Penumbra, Inc: Consultant (Ongoing)
• JW

  Jose Wiley, MD, MPH

  Chief of Cardiology
  Tulane University School of Medicine
  New Orleans, Louisiana, United States

  No relationships to disclose

Presentations:

• 9:00 AM – 9:10 AM ET

  Atherectomy Use Is Associated With Lower Rates Of Major Adverse Limb Events Among Adults Undergoing Femoropopliteal Interventions: Insights From The Vascular Quality Initiative Registry
  

  Speaker: Valery S. Effoe, MD, MS – Aurora Health Care St. Luke's Medical Center
• 9:10 AM – 9:15 AM ET

  Panel Discussion
• 9:15 AM – 9:25 AM ET

  Five-Year Results from the IMPERIAL Randomized Study of Eluvia and Zilver PTX Drug-Eluting Stents and the Long Lesion Substudy for Femoropopliteal Artery Disease
  

  Speaker: William A. Gray, MD, FSCAI – Main Line Health
• 9:25 AM – 9:30 AM ET

  Panel Discussion
• 9:30 AM – 9:40 AM ET

  Safety Of Orbital Atherectomy In Patients Without Distal Embolic Protection In Single Vessel Infra-popliteal Artery Runoff
  

  Speaker: Emily Schultz, DO – Northwell Lenox Hill Hospital
• 9:40 AM – 9:45 AM ET

  Panel Discussion
• 9:45 AM – 9:55 AM ET

  Drug-eluting Stent Versus Bare Metal Stents For Femoropopliteal Peripheral Artery Disease: Asystematic Review And Meta-analysi
  

  Speaker: Waiel Abusnina, MD (he/him/his) – Creighton University
• 9:55 AM – 10:00 AM ET

  Panel Discussion
• 10:00 AM ET

  Adjourn